Aluminum removal by peritoneal dialysis: Intravenous vs. intraperitoneal deferoxamine
- 1 December 1986
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 30 (6), 944-948
- https://doi.org/10.1038/ki.1986.277
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- SUCCESSFUL TREATMENT OF ALUMINIUM ENCEPHALOPATHY BY INTRAPERITONEAL DESFERRIOXAMINEThe Lancet, 1984
- Aluminum Hyoroxioe-Inouceo Osteomalacia, Encephalopathy ANO Hyperaluminemia in CAPO. Treatment with OesferrioxaminePeritoneal Dialysis International, 1984
- DESFERRIOXAMINE SUPPOSITORIESThe Lancet, 1983
- Iron removal during continuous ambulatory peritoneal dialysis using deferoxamineKidney International, 1983
- FRACTURE OSTEOMALACIA, CAPD, AND ALUMINIUMThe Lancet, 1983
- ORAL DESFERRIOXAMINE IN YOUNG PATIENTS WITH THALASSAEMIAThe Lancet, 1981
- IRON CHELATION WITH ORAL DESFERRIOXAMINEThe Lancet, 1980
- Enhancement of Aluminium Removal by Desferrioxamine in a Patient on Continuous Ambulatory Peritoneal Dialysis with DementiaPeritoneal Dialysis International, 1980
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977